Abstract
AbstractA new type of non‐nucleoside HIV‐1 reverse transcriptase inhibitors in phthalimide series has been synthesized from either the reaction of N‐carboethoxyphthalimide with amines or phthalimide with appropriate alkyl halides. The in vitro inhibitory activity of the synthesized compounds was studied by a radiometric assay at a concentration of 200 µg/mL using poly(rA)·oligo(dT) as a template‐primer and methyl‐[3H]dTTP as a substrate. The three most potent compounds, N‐(m,p‐dihydroxybenzyl)phthalimide (11), N‐[2‐(α‐furyl)ethyl]phthalimide (29) and N‐(5‐methylpyrazin‐2‐ylmethyl)phthalimide (25) exhibited IC50 values of 60.90, 98.10 and 120.75 µg/mL, respectively, lower than IC50 of delavirdine (502.22 µg/mL, using poly(rA)·oligo(dT) as a template‐primer and [3H]dTTP as a substrate).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
